Please login to the form below

Not currently logged in
Email:
Password:

Ipsen searches for new CEO after splitting top roles

Structural reshuffle aimed at accelerating international development

IpsenIpsen has started a hunt for a new chief executive after deciding to separate the CEO and chairman roles and after the departure of deputy CEO Christel Bories.

The current CEO of the French company, Marc de Garidel, will become chairman once the new CEO is appointed, said Ipsen, which hopes to fill the position within the next few months. Bories has departed after two years at the drugmaker, citing 'disagreements' with the board over strategy.

Analysts have suggested that Bories' departure may have been prompted by a decision by the board to look outside the company for a new CEO.

In a statement, Ipsen said Bories had made a "significant contribution to the operational transformation and improved results" at the company. It also said that its 2015 financial objectives and outlook for 2020 remain unchanged.

Splitting the two senior roles "meets the need for our group to accelerate its international development in an increasingly complex environment", commented de Garidel, with the new CEO focusing on business strategy while as non-executive chairman de Garidel "… will be able to focus fully on leading and animating the board of directors".

Specialty drugmaker Ipsen is in the process of a revamp of its business and has said expansion into emerging markets is a key strategic priority as sales in France have been impacted by government moves to drive generic drug use.

The company has also been building up its neuroendocrine tumours (NET) franchise, recently launching Somatuline (lanreotide) in the US and Europe and acquiring OctreoPharm Sciences, which has a NET therapy in early development, for $50m.

Last August, the company also reported positive phase III results for telotristat in carcinoid syndrome in NET patients. Ipsen licenses the drug from Lexicon Pharmaceuticals and has rights outside the US and Japan.

Article by
Phil Taylor

17th February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

Anthill_icon_Green_02_Digital.png
How to get your sales force to use digital tools
You have the perfect digital strategy. You provide the most advanced digital sales tools. You power it with amazing content. And then discover that customer-facing staff aren’t using it. Wait....
Highlights: Ashfield leads by example, engaging attendees at Pharma Forum
During this year’s Pharma Forum, held at the Gaylord National Convention Center in National Harbor, Maryland, David Kerr (Senior Director of Creative & Production Services) co-hosted an insightful session surrounding...
How to find pharma content that inspires your audience
Getting your customers’ attention begins with presenting pharma content that speaks to their needs and wants effectively....

Infographics